Open navigation
Search
Search

Select your region

Pavel Dřimal
Senior Associate

Pavel Dřímal

Languages
  • Czech
  • Slovak
  • English
Social media

Pavel is a senior associate in the Commercial, Regulatory and Disputes Team at CMS Prague. He is a key member of the local life-sciences practice. 

Pavel provides advice to life-science companies on health, regulatory, compliance and corporate law issues. Pavel spent over a year on secondment with a global pharmaceutical company where he was primarily responsible for business-conduct matters in the Czech Republic and Slovakia. He also has extensive experience in drafting and negotiating general business contracts, including business conditions. He has also contributed to and led several comprehensive due diligence projects and internal investigations. Pavel advises Czech and international companies regarding their market entry into the Czech Republic. Pavel regularly provides trainings and presentations to healthcare clients on various topics, including public procurement and relationships with healthcare professionals. 

Pavel also supports various clients on meeting their on-going legal obligations in terms of filings with relevant registers, organising annual general meetings and board meetings. 

Relevant experience

  • Advent International and its portfolio company Zentiva on the acquisition of the CEE assets of Alvogen. 
  • A global pharmaceutical corporation on an internal investigation related to a potential misuse of grants and donations funds and pharmaceutical as samples.
  • A global medical devices company on several criminal investigations on alleged bribery, corruption and compliance issues.
  • Various pharmaceutical companies on public procurement issues in public tenders.
  • Various pharmaceutical and MedTech companies on clinical trials, including rules on informed consent for trial subjects. 
  • A global pharmaceutical company in administrative proceedings with the Czech State Institute for Drug Control and the Czech Office for the Protection of Competition regarding their distribution model.
  • A global medical products and technologies company on pricing and reimbursement of pharmaceuticals, including negotiation of contracts with sick funds.
  • A multinational biopharmaceutical company on its liability in clinical trials of pharmaceuticals.
  • An original drug manufacturer on court disputes against various manufacturers of generic drugs.
  • A global pharmaceuticals company on court disputes with a Czech wholesaler.
     

Memberships & Roles

  • Member of the Czech Bar Association

Education

  • 2011 – Law Degree, Charles University, Prague 
Practice Areas

Further reading

  • CMS advises on the sale of LBBW Bank Czech Republic

  • CMS advises Triglav insurance group on sale of Triglav pojišťovna, a.s.

Insights by Pavel

CMS advises Advent International on EUR 4.1bn sale of Zentiva to GTCR

15 Sep 2025 2 min read

CEE Expert Guide on the reimbursement of orphan drugs

17 Apr 2023 3 min read

Czech health ministry drafts pharmaceuticals act amendment and sets up working group to respond to drug shortages

09 Jan 2023 4 min read

Changes to the Czech Public Health Insurance Act

02 Feb 2022 3 min read
Back to top Back to top
You will now find all Law-Now content on CMS.law